Authors: Schouten-van Meeteren, AYN van der Valk, P van der Linden, HC Moll, AC Imhof, SM Huismans, DR Loonen, AH Veerman, AJP

Citation: Ayn. Schouten-van Meeteren et al., Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay, CANCER, 92(11), 2001, pp. 2933-2940

Authors: Ramakers-van Woerden, NL Pieters, R Slater, RM Loonen, AH Beverloo, HB van Drunen, E Heyman, M Moreno, TC Rots, MG van Wering, ER Kamps, WA Janka-Schaub, GE Veerman, AJP

Citation: Nl. Ramakers-van Woerden et al., In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia, BR J HAEM, 112(3), 2001, pp. 680-690

Authors: de Haas, TGKJ Zwaan, CM Wondergem, MJ Pieters, R Kaspers, GJL Loonen, AH Rottier, MMA Wunsche, R Creutzig, U Bartl, S Hahlen, K Broxterman, HJ Ossenkoppele, GJ Veerman, AJP

Citation: Tgkj. De Haas et al., In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children, HEMAT BLOOD, 40, 2001, pp. 244-250

Authors: Ramakers-van Woerden, NL Pieters, R Loonen, AH Hubeek, I van Drunen, E Beverloo, HB Slater, RM Harbott, J Seyfarth, J van Wering, ER Hahlen, K Schmiegelow, K Janka-Schaub, GE Veerman, AJP

Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099

Authors: Broxterman, HJ Sonneveld, P Pieters, R Lankelma, J Eekman, CA Loonen, AH Schoester, M Ossenkoppele, GJ Lowenberg, B Pinedo, HM Schuurhuis, GJ

Citation: Hj. Broxterman et al., Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia, LEUKEMIA, 13(2), 1999, pp. 258-265